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Involvement in treatment decision-making:  
its meaning to people with diabetes and implications for conceptualisation 
 
Abstract: (293) 
Patient involvement in decision-making is widely regarded as an important feature of 
good quality healthcare. Policy-makers have been particularly concerned to ensure that 
patients are informed about and enabled to choose between relevant treatment options, 
but it is not clear how patients understand and value involvement.  
We investigated the meaning of involvement in treatment decision-making for people 
with diabetes. We conducted semi-structured interviews with 18 people aged between 
20 and 79 who had type 1 or type 2 diabetes. We used several strategies to probe their 
understandings of involvement, including discussion of how they would respond to a 
question about involvement in treatment decisions that appears on the National Patient 
Survey used to monitor the quality of healthcare in England.  
Participants associated involvement in decision-making with a number of features 
relating to: the ethos and feel of healthcare encounters (welcoming; respectful; 
facilitative of patients’ contributions; and non-judgemental); communication about 
health problems (practitioners attending to patients’ views and patients feeling listened 
to; practitioners giving clear explanations based on their professional knowledge and 
patients understanding these); and communication about treatments (practitioners 
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explaining treatment rationales in ways that patients understand and enabling patients to 
feel they have a say).  
Our findings have implications for practical attempts to involve patients in decisions 
about their care and for the conceptualisation and assessment of patient involvement. 
They suggest that practitioners who aspire to facilitate patient involvement should 
attend to the ethos they foster in consultations and the way they discuss problems as 
well as to the provision of information about treatment options and the scope patients 
have to influence decisions. Models and taxonomies of patient involvement in decision-
making need to be developed to accommodate both problem-solving phases and the 






Patient involvement in treatment decision-making is widely regarded as a 
feature of good quality healthcare. In many western nations it is advocated by state 
health departments and leading organisations of health professionals. In the context of 
decisions about professionally-controlled interventions such as prescription medicines 
and surgery, attention has generally focused on the information that is given to patients 
about relevant options, and on ensuring that decisions reflect patients’ free, informed, 
deliberated preferences (Kukla, 2005). This reflects the choice-centred notion of 
professional respect for patient autonomy that currently dominates bioethics (see 
Beauchamp & Childress, 2001).   
Although efforts to promote patient involvement are not new, research continues 
to suggest that patients are not routinely enabled to make free, informed and deliberated 
treatment choices. Studies of consultations identify deficiencies in the extent to which 
health professionals tell patients about healthcare options and elicit their views about 
these (Elwyn, Hutchings, Edwards, Rapport, Wensing, Cheung et al, 2005; van den 
Brink-Muinen, van Dulmen, de Haes, Visser, Schellevis & Bensing, 2006); studies of 
patients’ perspectives on decision-making find that many think that their doctors rather 
than they made key decisions about their treatment (Ford, Schofield & Hope, 2003; 
Entwistle, Watt, Gilhooly, Bugge, Haites & Walker, 2004); and studies of patients’ 
understandings of and attitudes towards particular interventions suggest that significant 
numbers have made some poorly-informed choices about their healthcare (Marteau, 
Dormandy & Michie, 2001; Fagerlin, Lakhani, Lantz, Janz, Morrow, Schwartz et al, 
2006).   
However, there is scope to debate why and to what extent these findings reflect 
problems with healthcare quality. Patients do not always expect or want to be given 
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information about a menu of treatment options and responsibility for making a choice 
between these (Say, Murtagh & Thomson, 2006). The reasons for this are still poorly 
understood, and the implications for evaluations of patient-practitioner communication 
and decision-making are contested (Entwistle, 2006).  
Patients who report preferences not to make or take responsibility for treatment 
decisions might still say they want to be involved in decision-making. A few qualitative 
investigations suggest that people might consider themselves to have been involved – 
and value feeling included - even though they have not been informed about and 
considered all the options and have not significantly influenced the selection of a course 
of action (Henman, Butow, Brown, Boyle & Tattersall, 2002; Beaver, Jones, 
Susnerwala, Craven, Tomlinson, Witham et al, 2005; Entwistle, Williams, Skea, 
MacLennan & Bhattacharya, 2006). Investigations of patients’ responses to structured 
questions about their involvement have found that people may take a broader range of 
issues into account than those emphasised in models that focus on information exchange 
and patient influence (Entwistle, Skea & O’Donnell, 2001; Davey, Lim, Butow, Barratt 
& Redman, 2004; Entwistle et al, 2004).  
 In England, the National Patient Survey that is used to monitor the quality of 
healthcare provision from patients’ perspectives assesses involvement in treatment 
decision-making with a question that invites patients to evaluate their involvement 
relative to their own preferences. Referring to a recent healthcare encounter or episode, 
it asks them “Were you involved as much as you wanted to be in decisions about your 
care and treatment?” and offers the response options “Yes, definitely”, “Yes, to some 
extent”, or “No” (Health Care Commission, 2005). (These response options have varied 
slightly across surveys.) In 2004 and 2005 around 31% of primary care patients and 
46% of inpatients indicated that they were not involved as much as they wanted to be 
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(Health Care Commission, 2006). However, the question does not impose any particular 
definition of involvement on respondents, and the forms and degrees of involvement 
that patients regard as desirable are poorly understood.    
We undertook a qualitative study to explore what it means to people with 
diabetes to be involved in decisions about their treatment in the contexts of both 
outpatient and inpatient care. We hoped to generate information that could inform both 
practical efforts to improve patients’ experiences of involvement and developments in 
the conceptualisation of involvement.  
The rationale for focusing on people with diabetes was that they are usually 
encouraged to develop an understanding of their condition and to engage actively in its 
management, so they should be well placed to participate in treatment decisions 
(Funnell, 2004). Also, they have experience of interacting with a variety of health 
professionals and of considering and revisiting a number of decisions relating to the 
management of their condition, so should be able to reflect on situations in which they 
have been more and less involved. 
 
Methods  
The study was approved by Grampian Research Ethics Committee (reference 
05/S0802/36).  
Recruitment and consent 
Adults with diabetes were recruited from four multi-practitioner outpatient 
diabetes clinic sessions in May-August 2005. Posters advertising the study were placed 
in the waiting room. MP was present in the waiting room to provide information sheets 
and explain the study. In the last two clinic sessions, she approached people from the 
gender/age groups previously under-represented in the sample to offer information 
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 MP took contact details for volunteers and telephoned them at least 24 
hours later to arrange interviews if they were still willing. A signature indicating 
consent was obtained prior to the interview.  
Data collection 
MP conducted semi-structured interviews in participants’ homes within a week 
of their outpatient visit. She asked participants first to describe the history of their 
diabetes and the healthcare they had received to date and then to describe their recent 
consultation(s) at the diabetes clinic, to identify any treatment decisions that were 
considered, and to comment on how this consultation compared with others they had 
experienced. She asked participants to answer the question about involvement in 
decisions from the National Patient Survey with reference to their recent consultation, 
and then to explain why they chose the response option that they did. People who had 
described contrasting experiences of healthcare in their initial accounts were asked 
whether and why they would have answered the question differently in relation to these. 
People who had been hospitalised in the last two years were also asked to describe their 
most recent hospitalisation and answer the National Patient Survey question with 
reference to that. Finally, all participants were invited to discuss what kinds of things 
made them feel involved or uninvolved in decisions about their treatment, and what 
involvement meant to them.  
Data analysis 
Interviews were audiorecorded and transcribed. All authors read a sample of 
transcripts and discussed provisional themes. MP and then VE worked systematically 
through all transcripts and created charts to summarise: issues that the researchers 
identified as relating to involvement in participants’ descriptions of their healthcare 
experiences; responses to the National Patient Survey and explanations given for these; 
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and participants’ statements about what made them feel involved (or not) and what 
involvement meant to them.  
The issues that participants associated with involvement were identified from 
their explanations for their responses to the National Patient Survey question and from 
statements explicitly about involvement. These issues were grouped into themes that 
could have practical relevance for health professionals. The themes were discussed 
among the authors, refined and checked against the charts to ensure all relevant issues 




Twenty-one people volunteered contact details at the clinic and eighteen were 
interviewed. All participants were white British. They included ten men and eight 
women from across the 20 to 79 year age range. Seven had Type 1 diabetes and eleven 
had Type 2 diabetes. They were between one and 31 years since diagnosis and followed 
a range of management regimes (Table 1).  
Participants’ accounts of their diabetes care to date were diverse. Most drew 
some contrasts between their experiences with different practitioners and clinical 
settings, particularly in relation to communication and perceived quality of care.  
Issues associated with involvement in decision-making  
Some participants answered direct questions about what it meant to them to be 
involved in treatment decisions without hesitation and using generalised conceptual 
statements. Others were more hesitant and some responses took the form of stories 
about particular healthcare incidents or descriptions of typical healthcare encounters. 
When asked whether they had thought much about their involvement in treatment 
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decisions before the interview, most participants indicated that they had not, although 
several reported having reflected on involvement when they had perceived a lack of it as 
problematic. However, all participants seemed to have an understanding of involvement 
that they could apply in relation to decisions about their treatment and use to answer and 
discuss their responses to the National Patient Survey question.  
Most of what participants said about their involvement in decisions focused on 
decisions about interventions for which health professionals are gatekeepers (e.g. 
prescription medications) and on communication between patients and health 
professionals (about health problems, health-related behaviours and healthcare 
interventions). Some participants also mentioned their involvement on a daily basis with 
decisions about diet, exercise, lifestyle and medication use. This latter is an important 
issue, but was not the focus of this study.    
We grouped the issues that patients associated with involvement into three broad 
themes that should have practical relevance for clinicians. Each theme has several 
related sub-themes:   
1. The ethos and feel of healthcare encounters  
When describing their healthcare to date, all participants made some reference to 
practitioners’ orientation or manner towards them and to how practitioners’ actions and 
features of healthcare settings made them feel. Participants associated several inter-
related, positively valued, features of the ‘feel’ of healthcare encounters - and the 
professional behaviours that contributed to these - with ‘involvement’:  
a) Friendly and welcoming 
Involvement was associated with practitioners being ‘friendly’ and 
‘approachable’ and patients feeling ‘welcome’. Several participants reported a lack of 
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involvement in situations in which practitioners made no time for friendly greetings and 
treated them with detachment.  
b) Interested and respectful of patients and their perspectives 
Participants could feel involved when practitioners treated them ‘as a person’, 
‘took an active interest’ and made them feel ‘on a level’ in discussions. In contrast, they 
did not feel involved if practitioners asserted their superiority and imposed their own 
views, disregarding patients’ experiential expertise or feelings. One important aspect of 
being treated as a person was being recognised as an individual with particular interests 
and concerns. Several participants indicated that they did not feel involved if 
practitioners showed no regard for their life circumstances and plans.    
c) Facilitative of patients’ contributions to discussions and condition management 
Participants associated involvement with practitioners making it easy for them to 
discuss their problems, inviting questions, ‘really listening’, answering their questions 
thoroughly, providing relevant information and explaining things well. Conversely, 
participants reported feeling less involved when practitioners appeared disinterested or 
were dismissive of what they had to say.  
d) Not unduly judgemental or patient-blaming   
Involvement was associated with patients feeling able to discuss their difficulties 
with self-care regimens or the achievement of target weights and blood sugar levels and 
being confident that they would not be negatively judged. Several participants noted 
that they had not felt involved when practitioners appeared to blame them for their 
health problems.   
Participants’ comments about involvement often incorporated several of these 
sub-themes. Examples are presented in Box 1.  
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 Some participants indicated that they could feel involved because they had a 
good relationship with a practitioner whom they had got to know. Conversely, several 
regarded a lack of continuity of carer as something that militated against their 
involvement. Continuity of carer could underpin some ‘ethos and feel’ features. For 
example, participants noted that it was easier to open up to and ask questions of a 
familiar, trusted ‘regular practitioner’, and that their regular practitioners were more 
interested and caring than others. However, continuity of carer was not always 
necessary to achieve these: one participant spoke most positively about a consultation 
with a locum GP, a diabetic himself, who expressed an empathetic interest and 
explained several issues that the participant had not previously understood. 
 
2. Communication about health problems 
Although our focus was on involvement in treatment decisions, communication 
about health problems featured significantly in the interviews.  
a) Practitioners elicit patients’ views of their situation and patients feel listened to  
Participants’ narratives confirmed the importance that patients attach to 
practitioners eliciting, listening empathetically to and taking seriously the patient’s own 
view of their symptoms, of how their diabetes affected their life (and not just how their 
life affected their diabetes), and of their current treatment regime. Participants also often 
associated these behaviours with involvement in treatment decisions. For example, one 
participant with numerous health problems recounted several occasions on which he had 
felt obliged to insist that doctors pay attention to the problems he was trying to tell them 
about. He explained that ‘Yes, definitely’ was the best answer to the National Patient 
Survey question in relation to his recent consultation:  
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Because I’m outspoken! And from past experience, it’s to have your input rather 
than let them tell you. You know your body, you should be telling them [about 
‘allergies and that’]. (03) 
 
Participants could feel a lack of involvement if their own concerns about blood sugar 
readings, symptoms or side-effects were dismissed or not taken up by their 
practitioners. For example, one woman (11) had been prescribed Metformin, which she 
took regularly and ‘didn’t have a problem with’ until she was told to increase the dose. 
At two tablets daily she started to have problems with diarrhoea. When she was told to 
increase the dose to four tablets daily, she expressed reluctance but was told she must 
‘give it a try’. The diarrhoea worsened to the extent that she felt unable to leave her 
home. When she telephoned the diabetic clinic, she was told emphatically that she must 
continue to take the tablets. The participant described this incident several times during 
her interview, stressing how frustrating and humiliating it was when her attempts to 
explain the effect Metformin was having on her were not listened to. She eventually 
contacted her GP who took the problem seriously and prescribed a different medication 
for her diabetes. When asked during her interview how she would have answered the 
National Patient Survey question if she had been asked it with reference to her contact 
with the clinic about the problems she had with the Metformin, she said that her 
response would have been “a definite no”.  
 However, a lack of involvement was not only associated with practitioners’ 
failing to listen to patients’ specific problem reports. Attention to patients’ feelings 
about the problems posed by their diabetes more generally was also seen as important. 
For example:   
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I just think I would be more involved if he said to me ‘[First name], I only see 
you every six months. Tell me, now, how you really feel, how you really deal 
with your diabetes, what problems, what do you feel the next 5 years are going 
to do for you?’ and stuff like that. There’s none of that. It’s just, get in, ‘yeah, 
yeah, the sugar levels are fine, they are 5.6, that’s good’. That’s it. (02) 
 
b) Practitioners explain health problems and patients understand  
Several participants mentioned that they had received (or taken in) relatively little 
information about diabetes and its management when they were first diagnosed. Only 
later had they found out what they now regarded as crucial information about their 
condition and its management - sometimes only after experiencing severe problems 
with hypo- or hyper-glycaemia. When talking about involvement, these participants in 
particular highlighted the importance of clear and timely explanations from practitioners 
about diabetes and about how and why preventable problems occurred. For example: 
I: Can you describe how involved you like to be, then?  
P: I like to know why. I don’t want to just go into a doctor and say, I am ill, the 
doctor ask me questions about my illness and then to be given a drug that fixes it 
– although that is nice sometimes. But with this particular illness [ketoacidosis] I 
want to know why it happened, what I could have done to prevent it, will it 
happen again? A lot more information than a “just take these and it won’t 
happen again” sort of situation. (08)  
 
However, the provision of too much complex information about diabetes could 
also militate against a sense of involvement if it resulted in the patient feeling 
overwhelmed. One participant, who seemed quite confused about some aspects of 
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diabetes and its management, explained that he would have responded “Yes, to some 
extent” to the National Patient Survey question because:  
She does involve you, but not to a fuller extent. She tries to explain things to 
you, and you’re trying to take it all in. Maybe there is a bit too much 
information, maybe not enough. (09) 
 
3. Communication about treatments  
All participants respected and wanted to avail themselves of practitioners’ 
expertise in relation to the management of their diabetes. They were generally inclined 
to accept treatment recommendations, although we heard several examples of patients 
having negotiated for something other than what their doctors first suggested. The few 
(including a nurse) who talked in terms of making ‘informed choices’ for themselves 
also noted that they valued a ‘steer’ from health professionals. However, there was a 
strong sense from across the interviews that people did not feel involved in decisions 
when practitioners ‘dictated’ a particular treatment without giving them a rationale for 
that treatment and without giving them any hint of a ‘say’.  
a) Practitioners explain and patients understand the reasons for treatment 
Participants frequently associated being given understandable explanations 
about the rationale for proposed treatments with involvement in decisions, as these two 
responses to the question “How involved do you like to be in treatment decisions?” 
illustrate:  
I prefer to know what is going on… I want to know if I am changing insulin why 
I am changing insulin… not just getting told “Yes, this would be better for you 
to change to”. Then you go away thinking “Why am I bothering?” I would 
prefer to know what is going on, why it is going on and things like that. (05) 
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 I like to be involved. I like to know why I have to take something and what it 
does to me. When they moved me onto Glimepride, it was explained what they 
did, and I was quite happy to take them. And I was on Glimepride for a while 
…, but the diabetes was getting worse and I needed something more, so they put 
me on to Rosiglitazone and explained what the Rosiglitazone did… I was quite 
happy because I understood what she was saying. She was telling me what each 
of the tablets were doing. (11) 
Two participants also suggested that they would feel more involved if practitioners 
proactively alerted them to the development of new treatments.  
 
b) Practitioners make room for patient influence and patients feel they have a say 
In addition to understanding the basis for possible or proposed treatments, all but 
one of the participants also suggested that to be involved they needed to have some kind 
of say in or about their treatment. This could happen in several ways. First, some 
participants talked in terms of practitioners understanding their situation and priorities 
and tailoring treatment recommendations accordingly. For example:  
I think the involvement is “Well, the three drugs here, X, Y, Z. This one will be 
good for you because you are an active person. This would be good if you were 
non active, and this, well that’s relatively new…” (02)  
Participant 11’s reports of the different responses she received when she complained of 
severe diarrhoea as a side effect of Metformin (see 2a above) are also relevant here.    
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Second, some participants focused on practitioners’ responses to their own 
suggestions about possible treatments or self management plans. They could feel 
involved if practitioners listened to and discussed these. For example:  
I: What kinds of things make you feel involved or uninvolved? 
P: I don’t know if it is relevant… but [I prefer to see doctors older than myself] 
to me that is important because I feel they do listen, and if I was to make a 
suggestion, even if it wasn’t a balanced suggestion, then they wouldn’t dismiss it 
but they would find something to work round it as well… I feel that the younger 
doctors are very headstrong and it is their word and that is it. (19) 
 
Third, and most frequently, involvement was associated with practitioners 
recommending rather than ordering particular treatments, phrasing treatment proposals 
as suggestions, asking patients for their opinions and in some sense giving them an 
option. For example:  
I: Why would you say that? [‘Yes, definitely’ in response to NPS question] 
P: When I was asked if I wanted to test myself, the doctor didn’t say I had to, he 
said if I wanted to. (20) 
 
I: So what kinds of things make you feel involved?  
P: I think being asked how I feel about what they are suggesting. I think being 
given choices, you know, things being explained properly to you and then the 
question being put to you, well how do you feel about this, or how will this fit 
into your lifestyle… I think if people took the time to sit with you and say, OK, 
here is where you are at, here are our concerns, if we offered you this, how 
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would it fit in with you, or there is an alternative to this, and give you choices 
that way. I think that would make me feel a lot more involved.  
I: So what kind of things … make you feel not involved? 
P: I think when you’re told this is what you need and there you go that is it.  
When it is as black and white as that then I don’t feel involved - when people are 
not taking account of how you are feeling. (01) 
 
For most participants it apparently sufficed that they felt they had scope to safely 
query and say no to the practitioner’s recommendation, and be confident that a 
reasonable alternative would be found if necessary.  
I: How possible do you think it is for you to be involved in decisions about your 
care? 
P: I think it is possible really, because if I don’t want to do something or take 
something then I can just say and he will come up with a different – like an 
alternative. (20) 
A few participants mentioned appreciating being told explicitly that if they tried a 
particular course of action and it did not suit them, an alternative could be found.    
Several participants stressed that having a say was of little use if they lacked 
relevant information or were unable to have a ‘meaningful discussion’ with their 
practitioners about what was being recommended and why. Few participants talked in 
terms of being given a menu of possibilities and information about each and being 
encouraged to select an option, but some did mention discussing possible medication 




 We have identified a number of features relating to communication about health 
problems and treatments and to the ethos and feel of consultations that people with 
diabetes associate with their involvement in treatment decisions. After considering the 
strengths and limitations of our study, we discuss the implications of our findings for 
the conceptualisation and assessment of patient involvement in decision-making and for 
practical efforts to promote patient involvement in decision-making.   
Our study has several strengths. Our participants included men and women of 
different ages with diverse experiences of diabetes. We invited them to discuss 
involvement in decision-making in specific recent consultations and previous healthcare 
episodes, and they were able to refer to a range of treatment decisions and to compare 
and contrast their experiences of involvement in these. We used several questioning 
strategies to explore what involvement meant to people. Also, for each of the features 
that we identified as important for involvement we have examples of (a) patients who 
experienced these features associating them positively with involvement and (b) 
patients who did not experience these features associating their absence with a lack of 
involvement.  
The main limitations of our study are: we studied only the views of people with 
diabetes; some participants may not have experienced or been aware of some possible 
forms of involvement in decision-making; and we did not ask participants to comment 
on features of healthcare that others had associated with involvement in decision-
making. Our interest in understanding what people consider when responding to the 
National Patient Survey question about involvement led to a focus particularly on 
involvement in the kinds of decisions considered during consultations with health 
professionals (mainly decisions about interventions to which health professionals 
control access). We acknowledge that different issues would probably have emerged if 
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we had focused on patients’ views about involvement in decision-making in relation to 
their daily self-management of their condition.  
Implications for conceptualisation 
We organised the issues that participants associated with involvement into three 
groups relating to: the ethos and feel of healthcare encounters; communication about 
health problems; and communication about treatments. These are not mutually 
exclusive. Communication about health problems and treatments may contribute to and 
reflect the ethos and feel of healthcare encounters, and communication about health 
problems and communication about treatments may overlap – consider, for example, 
discussions about treatment side effects. However, our groupings serve to draw 
attention to two issues (communication about problems and the ethos and feel of 
consultations) that have been neglected in considerations of patient involvement that 
have focused particularly on the exchange of information about treatment options and 
patients’ influence on treatment selection.  
Communication about problems 
Clinical/academic models of patient-professional interaction during decision-
making about the treatment of health problems often assume a clear and agreed problem 
(usually a specific diagnosis) as a starting point. Many of our participants, however, 
included communication about their health problems among the topics they associated 
with involvement in treatment decision-making. Involvement was associated with 
health professionals attending to patients’ experienced difficulties, understandings of 
their problems, and priorities for treatment and life.  
This finding is consistent with an analysis of consultation recordings that 
identified attention to patients’ thoughts about health problems as an important feature 
of  ‘bilateral’ approaches to decision-making by practitioners (Collins, Drew, Watt, 
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Entwistle, 2005). It may have been particularly apparent in our data because all 
participants had a long-term health problem. However, it lends support from a patient 
perspective to recent suggestions that models of patient-professional interaction or 
patient involvement during decision-making need to accommodate problem clarification 
and prioritisation, especially if the health problems to be addressed are complex or may 
be differently understood and prioritised by patients and health professionals (Entwistle 
& Watt, 2006; Murray, Charles and Gafni, 2006; Bugge, Entwistle & Watt, 2006).  
The ethos and feel of interactions   
It was striking that in their reflections on involvement in treatment decisions, our 
study participants placed a significant emphasis on the tone or manner of health 
professionals’ communication, the interpersonal or relational messages that were 
conveyed by this, and the way they felt during consultations. Their subjective 
experiences of being respected, encouraged and enabled (or not) were important 
influences on their sense of involvement (or otherwise) in treatment decisions. This is in 
some contrast to the emphasis within the dominant policy/professional discourse about 
patient involvement which emphasises the content of information exchanged about 
treatment options and patients’ preferences relating to these options. 
The identification of features of the ethos and feel of interactions as important 
aspects of patient involvement in decision-making might in part be an artefact of 
patients’ tendencies to bring a broad range of concerns to interviews and be willing to 
associate anything good about communication in healthcare with involvement in 
decisions about their treatment. However, several considerations lead us to think that 
these features should be considered integral to the concept of patient involvement in 
treatment decision-making.  
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First, in our own study, participants referred to these features frequently, 
including in response to carefully worded questions about decision-making. They spoke 
about issues relating to involvement with practitioners even though questions were 
phrased in terms of involvement in treatment decision-making (see Entwistle & Watt, 
2006).  
Second, the published findings from studies of patients’ perspectives on related 
concepts also suggest that features grouped under our ‘ethos and feel’ heading are 
considered by patients to be salient for involvement in decision-making. For example: 
consumers who were asked about the outcomes that should be assessed in research into 
shared decision-making noted that they could not achieve the confidence required to 
participate in shared decision-making if they did not feel respected (Edwards, Elwyn, 
Smith, Williams & Thornton, 2001); adults who had been nominated as expert self-
managers of their diabetes reported in the context of a study about empowerment that 
participatory decision-making was difficult to achieve when practitioners positioned 
themselves as the expert or sole authority (Paterson, 2001); acute medical and surgical 
patients who were asked about their preferences for involvement in decisions about their 
care identified clinicians’ disinterest as a barrier to participation (Doherty & Doherty, 
2003); and UK citizens who were asked about involvement in consultations made 
comments to the effect that: informing a patient is insufficient for involvement if there 
is ‘no contact’ in the discussion; there is a need for rapport and a feeling of having a 
discussion over and above an exchange of questions and answers; and it is of key 
importance that patients feel that they and their opinions are valued (Thompson, 2007).  
Third, involvement does have a relational dimension and it is a function of 
subjective perceptions of engagement and affinity as well as of the more readily 
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observable aspects of action and information exchange. There is no obvious reason for 
excluding these from considerations of patient involvement in decision-making.  
All this suggests that the models or taxonomies of patient involvement that 
emphasise information exchange and patient influence over option selection will need to 
be expanded or modified to accommodate the relational and subjective factors that our 
‘ethos and feel’ features relate to. There have already been a few moves in this 
direction. Montori, Gafni and Charles (2006) recently suggested adding ‘establishing an 
ongoing partnership’ as a new first phase of the shared treatment decision-making 
model, and encouraged recognition that this partnership would and should evolve over 
the course of patient-professional communications. Entwistle and Watt (2006) proposed 
a conceptual framework for examining involvement in decision-making in which 
communication relating to decision-making was presented as central and patients’ and 
clinicians’ feelings and views about their relationships with each other featured as two 
of six other domains of involvement. Our findings endorse the inclusion of at least the 
patient’s subjective perspective on the relationship. They also suggest that the central 
domain of this framework might need to be developed to emphasise other aspects of 
interpersonal communication in addition to the transmission of information about 
particular topics. These could include verbal and non-verbal cues that signal or foster 
understanding, respect, trust, relational orientation and commitment.  
The incorporation of ethos and feel factors within the conceptualisation of 
patient involvement will complicate attempts to assess the extent or quality of patient 
involvement. They tend to broaden the focus of interest out beyond a punctate treatment 
decision. Also, while they are at least partially constituted by or within instances of 
information exchange, they nonetheless form an additional dimension of interest and 
will thus be difficult to incorporate within hierarchical taxonomies that distinguish 
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between levels of involvement on the basis of patterns of topic-focused information 
exchange and influence over option selection.  
The relative significance of ethos and feel factors within an overall assessment 
of involvement is likely to vary for patients with different characteristics and facing 
different decisions. The weighting that should be given to them will need further 
consideration. However, their importance was highlighted by a survey of recently 
discharged hospital inpatients which found that being treated with respect and dignity, 
and having confidence and trust in healthcare providers were more strongly associated 
with patients’ willingness to recommend a hospital than having been given enough say 
about treatment (Joffe, Manocchia, Weeks & Cleary, 2003).     
Implications for policy and practice 
Our findings suggest that if policy-makers and healthcare practitioners aspire to 
involve patients in decisions in the ways that patients appreciate, they will need to 
ensure that patients feel welcome, respected, supported as contributors and cared for in 
healthcare encounters; that their experiences of and concerns about their health 
problems and treatment are seriously attended to; and that they are given explanations 
about the medical view of their health problems that they can understand. Our 
participants varied in terms of their expectations about information about treatment 
options and their influence over decisions, but it seems that a minimum requirement for 
a sense of involvement is having an understandable rationale for any proposed treatment 
and a belief that they could safely query and decline any proposed treatments and 
explore alternatives with their clinician if required.   
Patients’ views about what matters are increasingly regarded as normative 
guides to the development and delivery of health services, but our study participants’ 
views cannot serve as comprehensively indicative of the forms that efforts to promote 
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patient involvement should take. We do not think our findings imply that efforts to 
ensure patients are well informed and enabled to appraise treatment options themselves 
are all misguided. Our participants might not have experienced or been able to imagine 
being offered information about several treatment options simultaneously and being 
supported in the appraisal of each of these against their relevant preferences. The forms 
of involvement they expressed interest in were probably constrained by what they were 
familiar with. The appropriateness in different contexts of different approaches to 
informing patients about options and enabling them to have a say remains contested.  
Our study findings also have practical implications for those tasked with 
addressing problems flagged up by responses to the National Patient Survey. They 
suggest that people who indicate they were not as involved as they wanted to be may be 
reflecting on disrespectful and disempowering communication from staff and/or a lack 
of attention to their views about their health problems as well (perhaps) as a lack of 
information about treatment options and/or a lack of opportunity to influence treatment 
selection in more than a veto-holding way. Healthcare providers who achieve low 
patient feedback scores on this question might need to do more than provide treatment 
menus and offer choice.   
Conclusion 
Our investigation of patients’ understandings of involvement in treatment 
decision-making has highlighted the insufficiency of models and practices that focus 
narrowly on the exchange of information about treatment options and the activation of 
patients as choosers. It leads us to suggest that clinicians and researchers with an 
interest in patient involvement in decision-making need to attend to communication 
about health problems and to the ethos and feel of patient-practitioner interactions.  
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Attention to the more diffuse relational and affective aspects of patient 
involvement in decision-making would be consistent with, and perhaps facilitative of, a 
proposed shift in emphasis for normative thinking about communication and decision-
making in healthcare. In particular it would be congruent with suggestions that 
bioethical concern should focus less intensely on ‘choice’ about ‘punctate decisions’ as 
a means of respecting autonomy, and pay more attention to a broader set of ethical 
considerations relating to respect for patients as persons (Joffe et al, 2003; Kukla, 2005; 
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Table 1: Participants’ self-reported characteristics 
ID Age group, 
Gender, 




















19 years  
Oral medication 
 
Worsening slightly  
(Not checked “for 
quite some time”)  






31 years  
Insulin  
Prescribed doses 
Well controlled None More “modern” insulin.  




1 year  











2 years  





Slight increase in blood 
sugar levels.  
To pay particular 








controlled, but more 
‘hypos’ recently.  
 
None ‘New’ insulin.  
Participant to consider 







22 years  
Insulin 
Prescribed doses. 
Well controlled  Heart and chest 
‘complaints’ 
Insulin doses.  















Improvement in blood 
sugar levels. 





8 years  
Insulin 
Self-adjusted doses 
Well controlled  None Weight. 










about diabetes).  
None Blood sugar readings. 
No changes to insulin 
regime or diet. Review 








recent switch to 
insulin 
Obesity Recent weight loss.   







14 years  
Oral medication 
 
Well controlled  
 
None “Nothing much”. 






17 years  
Insulin 
Self adjusted doses 
Well controlled but  
intentionally has 
blood sugars around 
10mmol/L to avoid 
‘hypos’ on long 
outings. 
None Weight. 
Advised to lose 4lbs. 
14 50–59 
Male 
Type 2  









Reasons for changes to 
diabetes medication 
during hospitalisation.  













Blood sugar levels,  
weight, smoking and 
drinking.  







4 years  
Oral medication 
 






500mg daily prescribed 
(patient not sure why) 




2 years  
  cholesterol, under-
active thyroid 






26 years  
Insulin 
Self-adjusted doses  
 
Well controlled 
7.3%.   
None Weight and HbA1c 
level.  







1 year  





Self-testing blood sugar 
at home. 
Participant will start. 
Note: Participant ID numbers were allocated when people agreed to be contacted about 
the study. The people allocated ID numbers 12, 18 and 21 were not interviewed.
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Box 1 
‘Involvement’ and the ‘ethos and feel’ of healthcare encounters 
 
Responses to questions about “What kinds of things make you feel involved?”  
… Just getting the opportunity to say what you want to say. You never feel that there is 
anything I couldn’t mention to my doctor. And again I don’t feel that I have to mention 
things… I don’t think that he would pressure me into saying anything… You don’t feel 
that they are saying “This is what you have to do” or “Whatever happens to you is your 
fault” kind of thing. (05) 
 
1c, 1d 
Involvement. … just giving me some flexibility and understanding about my lifestyle 
and my personal life and not dictating going back to the old school doctoring diabetes. 
And a bit of leeway. It makes me feel more confident that I can ask more and I hear more 
what they have to say as well. (19) 
 
1b, 1c 
Mainly discussion. I mean as a patient you do tend to think (well, I do!) if you try and get 
involved in the discussion process, is the consultant or the doctor feeling that “Look, I 
am the expert, don’t question me. You are asking questions. Don’t question my ability” 
type of thing. Are you interfering? You do sometimes feel that. (13) 
 
1b, 1c 
Explanations for responses to National Patient Survey question  
[Yes, definitely] Because … I got the feeling that if there was anything that I wanted to 
ask her she would have answered to the best of her ability and she was very open and 
friendly. She wasn’t the least bit intimidating or anything like that. (04) 
 
1a 
[Yes, definitely] … Well, the fact that she asks [about various other problems as well as 




[Yes, to some extent] … I think the impression I’ve always had with the diabetic clinic is 
they try really hard to deal with the patients they have. I don’t think they have time to do 
themselves justice you know because I suppose they’re just seeing a line of people going 
past. There’s no relationship with a doctor or nurse… They just see you as a face that’s 
going past them. Did you have cotton wool in your ear. They take the blood, they 
scribble it up, they write a number on it, “OK, down you go and sit down there”…[14] 
 
1b 
[Yes, definitely] … I feel I am in very good charge of my own diabetes because I have 
had it for so long… They have recommended, obviously they like me to exercise … and 
I did say that it has been a bit hard to do it at the moment [due to working long hours in 
response to an opportunity with tight deadlines]… I am comfortable in the fact that I can 
take a week off being a strict regimental diabetic as long as I keep an eye on my levels. 
… I’m comfortable enough to tell my doctor this and he is comfortable enough knowing 
the fact that I will go back to being in control again. (19)  
 
1d 
Other questions  
I: Is there anything else you would like to say about involvement in decisions?  
P: I cannot see how you can be involved when it’s so impersonal… You cannot get 
involved… I get the impression you get these young doctors that are doing 6 months in 
the diabetic clinic and it’s knocking in time for them (11) 
1a, 1b 
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